Amy Zheng

Amy Zheng

Auto-generated profile, based on publicly available information

Amy Zheng

Department of Epidemiology Boston University School of Public Health Boston Massachusetts USA

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 April 2025 in PLOS Global Public Health
Verified
Journal Article
Open access
PDF file
NVN. Venkatesan
N. Venkatesan
LFL. Faust
L. Faust
RLR. Lobo
R. Lobo
HEH. Enkh-Amgalan
H. Enkh-Amgalan
TKT. Kunor
T. Kunor
JGJ.E. Golub
J.E. Golub
Tuberculosis (TB) is an infectious disease closely intertwined with stigma, discrimination, and the social determinants of health. Communities of people affected by TB are experts in their care pathways, but the TB field continues to fall short of meaningfully engaging communities in TB research. This is a missed opportunity to improve the quality, relevance, person-centeredness, positive impact, and sustainability of TB research outputs. We acknowledge the important progress that has been made to date regarding community engagement in TB, but emphasize persisting barriers to meaningful engagement, and the urgent need for updated and comprehensive TB-specific standards for such engagement in research. We highlight that core components of these standards should include the mobilisation of communities affected by TB, bilateral training in community engagement (for researchers and communities), as well as ensuring appropriate remuneration, representation of priority groups, and the use of non-stigmatising language in the engagement process. In addition, to meaningfully incorporate the experiences and expertise of communities affected by TB, their engagement in the research process should occur as early as possible, ideally before research priorities and directions are set, and the scope of the research should encompass questions and outputs relevant to the community. Further, knowledge-sharing between researchers and the community should be ensured, not only of the research outputs but also regarding the engagement process itself, so that lessons learned can be carried forward. Lastly, the sustainability of community engagement processes (whether within institutions or projects) should be ensured, including through adequate funding for such engagement and the training, community mobilisation and relationship-building that this requires.

5 September 2025 in Journal of the International AIDS Society
Verified
Journal Article
Open access
AZAmy Zheng
Amy Zheng
EKEmma M. Kileel
Emma M. Kileel
ABAlana T. Brennan
Alana T. Brennan
DFDavid B. Flynn
David B. Flynn
SRSydney Rosen
Sydney Rosen
MFMatthew P. Fox
Matthew P. Fox
Introduction: We previously published a systematic review evaluating retention in care after antiretroviral therapy initiation among adults in low‐ and middle‐income countries from 2008 to 2013. This review evaluates retention after the implementation of Universal Test and Treat (UTT) in 2015.Methods: We searched PubMed, ISI Web of Science, Cochrane Database of Systematic Reviews and EMBASE for studies published 1 January 2017, through 31 December 2024 and searched conference abstract repositories from AIDS, IAS and CROI from 2015 to 2024. Retention for each study was estimated using (1) simple averages and (2) interpolated for missing time points through the last reported time point. Our outcomes were all‐cause attrition and retention. We estimated retention rates using a generalized linear mixed model (GLMM) with a logit distribution using interpolated data.Results: Seventy studies met our inclusion criteria. Most studies came from Africa, with very few from Europe and Asia. Few studies reported retention past the first 12 months following treatment initiation. Across all studies, we estimated simple average retention without interpolation of missing time points to be 72.6% at 12 months, 75.2% at 24 months, 67.7% at 36 months and 64.8% at 48 months. Utilizing a GLMM model, we estimated retention to be 79.6% at 12 months, 81.2% at 24 months, 75.6% at 36 months and 72.8% at 48 months. Whereas in our prior 2015 review, we estimated retention rates to be 86.0% at 12 months, 79.0% at 24 months, 75.0% at 36 months, and 69.0% at 48 months. These results generally reflect retention at the initiating facility and omit the effect of unreported transfers.Discussion: Retention in care at 36 months was estimated to be between 67% and 75%. Compared to results from our prior review, retention is largely similar in the post‐UTT era. Further research evaluating retention in other geographic areas (i.e. Latin America and the Caribbean, Europe, and Asia) is needed.Conclusions: Attrition after the first 2 years in treatment remains a concern, and concerted efforts should be made to ensure patients remain engaged in care over their lifetime. The impact of PEPFAR's recent cuts needs to be evaluated further to understand the effect it may have on long‐term retention.

18 December 2024 in medRxiv
Verified
Preprint
Open access
PDF file
AZAmy Zheng
Amy Zheng
EKEmma M. Kileel
Emma M. Kileel
ABAlana T. Brennan
Alana T. Brennan
DFDavid B. Flynn
David B. Flynn
SRSydney Rosen
Sydney Rosen
MFMatthew P. Fox
Matthew P. Fox
Background We previously published a systematic review evaluating retention in care after antiretroviral therapy treatment initiation among adults in low- and middle-income countries. We estimated retention at 36 months to be at 74% for studies published from 2008-2013. This review evaluates retention after the implementation of Universal Test and Treat in 2015. Methods We searched PubMed, ISI Web of Science, Cochrane Database of Systematic Reviews, and EMBASE for studies published between January 1, 2017, to December 31, 2023 and searched conference abstract repositories from AIDS, IAS, and CROI from 2015-2023. Retention for each study was estimated using 1) simple averages and 2) interpolated for missing timepoints through the last reported timepoint. All-cause attrition for all participants who initiated first-line treatment in low- and middle-income countries was estimated. Overall retention rates were estimated using a generalized linear mixed model with a logit distribution using the interpolated data. Results A total of 65 studies met our criteria for inclusion for the systematic review. Most studies came from Africa with very few from Europe and Asia. Very few studies reported retention past the first 12 months following treatment initiation. Across all studies, we estimated simple average retention with no interpolation of missing timepoints to be 72.6% at 12 months, 73.2%, at 24 months, 59.8% at 36 months, and 49.4% at 48 months. Utilizing a GLMM model, we estimated retention to be 86.0% at 6 months, 80.0% at 12 months, 82.0% at 24 months, 71.0% at 36 months, and 57.0% at 48 months. In comparison, our prior review conducted in 2015, estimated retention rates to be 91.0% at 6 months, 86.0% at 12 months, 79.0% at 24 months, 75% at 36 months, and 69% at 48 months. These results generally reflect retention at the initiating facility and omit the effect of unreported transfers. Conclusions Retention in care at 36 months was estimated to be between 60% and 71%. Compared to results from our prior review, retention has stayed largely similar in the post-UTT era. Further research evaluating retention in other geographic areas (i.e., Latin America and the Caribbean, Europe, and Asia) is needed. Funding ATB and EK was supported by the National Institute of Diabetes and Digestive and Kidney Diseases K01DK116929. SR was supported by INV-031690 from the Gates Foundation to Boston University. AZ was supported by the National Institute of Allergy and Infectious Diseases 1F31AI179292-01A1. Research reported in this publication is supported by the National Institute of Mental Health of the National Institutes of Health under Award Number R01MH121998. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

1 June 2025 in JAIDS Journal of Acquired Immune Deficiency Syndromes
Verified
Journal Article
Open access
AZAmy Zheng
Amy Zheng
MFMatthew P. Dsc Fox
Matthew P. Dsc Fox
RGRoss MSocSci Greener
Ross MSocSci Greener
EKEmma M. Kileel
Emma M. Kileel
JBJacob Bor
Jacob Bor
MMMhairi PhD Maskew
Mhairi PhD Maskew
Background: In 2019, South Africa's Antiretroviral Therapy (ART) Treatment Guidelines replaced efavirenz with dolutegravir in first-line ART. Setting: We assessed the impact of this national guideline change on retention and viral suppression in the Themba Lethu Clinical Cohort, Johannesburg, South Africa. We applied a regression discontinuity design in a prospective cohort study of 1654 adults living with HIV initiating first-line ART within 12 months (±12 months) of the guideline change. Methods: We compared outcomes in individuals presenting just before and after the guideline change and estimated intention-to-treat effects on initiating a dolutegravir- vs efavirenz-based regimen. Primary outcomes were retention and viral suppression. Participants were defined as retained in care if a visit took place within ±3 months of the 6-month end point. Viral suppression was defined as having a viral load ≤1000 copies/mL 3 months before and up to 6 months after the 6-month end point. Results: The 2019 guideline change led to an increase in uptake of dolutegravir. We noted a 26.6 percentage point increase in the proportion initiating dolutegravir [95% Confidence Interval (CI): 14.1 to 38.6]. We saw a small increase in viral suppression [Risk Difference (RD): 7.4 percentage points; 95% CI: −1.6 to 16.5] and no change in retention (RD: −1.7 percentage points; 95% CI: −13.9 to 10.5) at 6 months, though our findings were imprecise. Conclusions: Our estimates suggest early uptake of the revised treatment guidelines after implementation. Despite this, there was no meaningful change in viral suppression and retention rates at 6 months.

15 July 2025 in Mayo Clinic Proceedings: Digital Health
Verified
Journal Article
Open access
AZAmy Zheng
Amy Zheng
LLLawrence Long
Lawrence Long
CGCaroline Govathson
Caroline Govathson
CCCandice Chetty-Makkan
Candice Chetty-Makkan
SMSarah Morris
Sarah Morris
SPSophie Pascoe
Sophie Pascoe
To understand what preferences are important to university students in South Africa when engaging with a hypothetical artificial intelligence-powered health care assistant (AIPHA) to access health information using a discrete choice experiment. We conducted an unlabeled, forced choice discrete choice experiment among adult South African university students through Prolific, an online research platform, from June 26, 2024 to August 31, 2024. Each choice option described a hypothetical AIPHA using 8 attribute characteristics (cost, confidentiality, security, health care topics, language, persona, access, and services). Participants were presented with 10 choice sets each comprised of 2 choice options and asked to choose between the 2. A conditional logit model was used. Three hundred participants were recruited and enrolled. Most participants were Black, born in South Africa, heterosexual, working for a wage, and had a mean age of 26.5 years (SD, 6.0). Language, security, and receiving personally tailored advice were the most important attributes for AIPHA. Participants strongly preferred the ability to communicate with the AIPHA in any South African language of their choosing instead of only English and receive information about health topics specific to their context including information on clinics geographically near them. The results were consistent when stratified by sex and socioeconomic status. Participants had strong preferences for security and language, which is in line with previous studies where successful uptake and implementation of such health interventions clearly addressed these concerns. These results build the evidence base for how we might engage young adults in health care through technology effectively.

31 January 2025 in medRxiv
Verified
Preprint
Open access
PDF file
AZA Zheng
A Zheng
LLL Long
L Long
CGC Govathson
C Govathson
CCC Chetty-Makkan
C Chetty-Makkan
SMS Morris
S Morris
SPS Pascoe
S Pascoe
Introduction South African young adults are at increased risk for HIV acquisition and other non-communicable diseases and face significant barriers to accessing healthcare services. The rapid development of artificial intelligence (AI), in particular AI-powered healthcare assistants (AIPHA), presents a unique opportunity to increase access to health information and linkage to healthcare services and providers. While successful implementation and uptake of such tools require understanding user preferences, limited understanding of these preferences exist. We sought to understand what preferences are important to university students in South Africa when engaging with a hypothetical AIPHA to access health information using a discrete choice experiment. Methods We conducted an unlabeled, forced choice discrete choice experiment among adult South African university students through Prolific Academic, an online research platform, in 2024. Each choice option described a hypothetical AIPHA using eight attribute characteristics (cost, confidentiality, security, healthcare topics, language, persona, access, services). Participants were presented with ten choice sets each comprised of two choice options and asked to choose between the two. A conditional logit model was used to evaluate preferences. Results 300 participants were recruited and enrolled. Most participants were Black, born in South Africa, heterosexual, working for a wage, and a mean age of 26.5 years (SD: 6.0). Results from the discrete choice experiment identified that language, security, and receiving personally tailored advice were the most important attributes for AIPHA. Participants strongly preferred the ability to communicate with the AIPHA in any South African language of their choosing instead of only English and to receive information about health topics specific to their context including information on clinics geographically near them. Results were consistent when stratified by sex and socioeconomic status. Conclusions Participants had strong preferences for security and language which is in line with previous studies where successful uptake and implementation of such health interventions clearly addressed these concerns. These results build the evidence base for how we might engage young adults in healthcare through technology effectively.